Incorporation of immunotherapy and biological targeted therapy in primary anti‐cancer treatment in gynecologic malignancy

Incorporation of immunotherapy and biological targeted therapy in primary anti‐cancer treatment in gynecologic malignancy

Synopsis Immunotherapy and/or biological targeted therapy is increasingly being incorporated into initial anti‐cancer treatment regimens for gynecologic malignancy from 2013‐2020 in the USA.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of gynecology and obstetrics 2024-12, Vol.167 (3), p.1257-1259
Hauptverfasser: Lee, Matthew W., Pino, Christian, Vallejo, Andrew, Wright, Jason D., Matsuo, Koji
Format: Artikel
Sprache:eng
Schlagworte:
gynecologic malignancy
immunotherapy
primary therapy
trend
USA
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Synopsis Immunotherapy and/or biological targeted therapy is increasingly being incorporated into initial anti‐cancer treatment regimens for gynecologic malignancy from 2013‐2020 in the USA.
ISSN:0020-7292
1879-3479
1879-3479
DOI:10.1002/ijgo.15780